Abstract PO4-15-09: Unraveling the Influence of Progesterone Receptor Status on Endocrine Therapy Sensitivity: Insight from Epigenetic and Fragmentomics Ctdna Profiling in Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer (MBC)